doi:10.1007/s12250-015-3660-x

[1]
Mengying Ji,, Kanghong Hu, 2017: Recent advances in the study of hepatitis B virus covalently closed circular DNA, Virologica Sinica, 32, 454-464. doi: 10.1007/s12250-017-4009-4
[2]
Zhanqi Dong, Qi Qin, Zhigang Hu, Peng Chen, Liang Huang, Xinling Zhang, Ting Tian, Cheng Lu, Minhui Pan, 2019: Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms, Virologica Sinica, 34, 444-453. doi: 10.1007/s12250-019-00121-4
[3]
Zhihao Zhang, Wei Hou, Shuliang Chen, 0: Updates on CRISPR-based gene editing in HIV-1/AIDS therapy, Virologica Sinica.
[4]
Zhihao Zhang, Wei Hou, Shuliang Chen, 2022: Updates on CRISPR-based gene editing in HIV-1/AIDS therapy, Virologica Sinica, 37, 1-10. doi: 10.1016/j.virs.2022.01.017
[5]
Jian Qiu, Bo Qin, Simon Rayner, Chun-chen Wu, Rong-juan Pei, Song Xu, Yun Wang, Xin-wen Chen, 2011: Novel Evidence Suggests Hepatitis B Virus Surface Proteins Participate in Regulation of HBV Genome Replication^*, Virologica Sinica, 26, 131-138. doi: 10.1007/s12250-011-3190-0
[6]
Xiaohui Tian, Fei Zhao, Zhikui Cheng, Ming Zhou, Xiaoguang Zhi, Jiafu Li, Kanghong Hu, 2013: GCN5 Acetyltransferase Inhibits PGC1α-induced Hepatitis B Virus Biosynthesis, Virologica Sinica, 28, 216-222. doi: 10.1007/s12250-013-3344-3
[7]
Xiaowei Xu, Sulin Ren, Xiaoxiao Chen, Jun Ge, Zhenxing Xu, Hongying Huang, Honglin Sun, Yue Gu, Tong Zhou, Jianqiang Li, Hanmei Xu, 2014: Generation of Hepatitis B virus PreS2-S antigen in Hansenula polymorpha, Virologica Sinica, 29, 403-409. doi: 10.1007/s12250-014-3508-9
[8]
You-hua XIE, Ran HONG, Wei LIU, Jing LIU, Jian-wei ZHAI, 2010: Development of Novel Therapeutics for Chronic Hepatitis B^*, Virologica Sinica, 25, 294-300. doi: 10.1007/s12250-010-3138-9
[9]
Jing Li, Yangyang Hu, Yifei Yuan, Yinan Zhao, Qiqi Han, Canyu Liu, Xue Hu, Yuan Zhou, Yun Wang, Yu Guo, Chunchen Wu, Xinwen Chen, Rongjuan Pei, 2021: Repurposing of Antazoline Hydrochloride as an Inhibitor of Hepatitis B Virus DNA Secretion, Virologica Sinica, 36, 501-509. doi: 10.1007/s12250-020-00306-2
[10]
Ke Zheng, Fang-Fang Jiang, Le Su, Xin Wang, Yu-Xin Chen, Huan-Chun Chen, Zheng-Fei Liu, 2020: Highly Efficient Base Editing in Viral Genome Based on Bacterial Artificial Chromosome Using a Cas9-Cytidine Deaminase Fused Protein, Virologica Sinica, 35, 191-199. doi: 10.1007/s12250-019-00175-4
[11]
Ina Schulte, E-juan ZHANG, Zhong-ji MENG, Rong-juan PEI, Mengji LU, Michael Roggendorf, 2008: Recent Advances in Research on Hepadnaviral Infection in the Woodchuck Model^*, Virologica Sinica, 23, 107-115. doi: 10.1007/s12250-008-2941-z
[12]
Li He, Aiping Zang, Min Du, Dapeng Ma, Chuanping Yuan, Chun Zhou, Jing Mu, Huanjing Shi, Dapeng Li, Xulin Huang, Qiang Deng, Jianhua Xiao, Huimin Yan, Lijian Hui, Ke Lan, Sidong Xiong, Xiaoxia Li, Zhong Huang, Hui Xiao, 2015: mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines, Virologica Sinica, 30, 174-189. doi: 10.1007/s12250-015-3606-3
[13]
Jianhao Cao, Shuhong Luo, Yuanyan Xiong, 2019: The Variability of Amino Acid Sequences in Hepatitis B Virus, Virologica Sinica, 34, 42-49. doi: 10.1007/s12250-018-0070-x
[14]
Xueyu Wang, Zhiqiang Wei, Yongfang Jiang, Zhongji Meng, Mengji Lu, 2021: mTOR Signaling: The Interface Linking Cellular Metabolism and Hepatitis B Virus Replication, Virologica Sinica, 36, 1303-1314. doi: 10.1007/s12250-021-00450-3
[15]
Zhikui Cheng, Ge Sun, Wei Guo, Yayun Huang, Weihua Sun, Fei Zhao, Kanghong Hu, 2015: Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines, Virologica Sinica, 30, 261-268. doi: 10.1007/s12250-015-3584-5
[16]
Jun Zhang, Tianhang Zheng, Xiaolei Zhou, Hong Wang, Zhaolong Li, Chen Huan, Baisong Zheng, Wenyan Zhang, 2021: ATP1B3 Restricts Hepatitis B Virus Replication Via Reducing the Expression of the Envelope Proteins, Virologica Sinica, 36, 678-691. doi: 10.1007/s12250-021-00346-2
[17]
Yingying Song, Shuyu Shou, Huimin Guo, Zixiang Gao, Nannan Liu, Yang Yang, Feifei Wang, Qiang Deng, Jing Liu, Youhua Xie, 2022: Establishment and characterization of a new cell culture system for hepatitis B virus replication and infection, Virologica Sinica, 37, 558-568. doi: 10.1016/j.virs.2022.05.002
[18]
Tingting Liu, Anlei Liu, Yong Liu, Shan Cen, Quan Zhang, 2022: In vitro investigation of HBV clinical isolates from Chinese patients reveals that genotype C isolates possess higher infectivity than genotype B isolates, Virologica Sinica, 37, 398-407. doi: 10.1016/j.virs.2022.03.008
[19]
Chunchen Wu, Baolin Li, Xiaoyong Zhang, Kaitao Zhao, Yingshan Chen, Yifei Yuan, Yan Liu, Rongjuan Chen, Dongping Xu, Xinwen Chen, Mengji Lu, 2019: Complementation of Wild-Type and Drug-Resistant Hepatitis B Virus Genomes to Maintain Viral Replication and Rescue Virion Production under Nucleos(t)ide Analogs, Virologica Sinica, 34, 377-385. doi: 10.1007/s12250-019-00143-y
[20]
Xinna Ma, Heng Li, Ying Gong, Feifei Liu, Xiankun Tong, Fenghua Zhu, Xiaoqian Yang, Li Yang, Jianping Zuo, 2022: Psoralen inhibits hepatitis B viral replication by down-regulating the host transcriptional machinery of viral promoters, Virologica Sinica, 37, 256-265. doi: 10.1016/j.virs.2022.01.027